Australia's largest stock trading and investment forum Australia's #1 stock forum

Biotechnology News

Clinuvel shares dip, even as CEO comes back from temp leave

After Clinuvel's (ASX:CUV) CEO Dr. Philippe Wolgen took time off back in March to respond to an "acute medical condition," it wasn't...

Jonathon Davidson

1 day ago

ASX News Healthcare Biotechnology

A long-run study looking into leading Firebrick Pharma (ASX:FRE) product Nasodine has suggested the nasal spray can be an effective treatment for the common cold following a dive into the company’s Phase III trials.Listen to the HotCopper podcast for in-depth discussions and insig...

4 days ago

ASX News Healthcare Biotechnology

Proteomics International (ASX:PIQ) has popped +6% after reporting the "high accuracy" of its blood test for throat cancer.

Jonathon Davidson

05 Jun 2025 13:24 (AEST)

ASX News Healthcare Biotechnology

Recce Pharmaceuticals (ASX:RCE) has successfully filled its coffers ahead of its Phase III clinical trials in Indonesia and Australia, with the company this week landing @firm commitments” to place the full shortfall in its capital raise.Listen to the HotCopper podcast for i...

04 Jun 2025 09:29 (AEST)

ASX News Healthcare Biotechnology

Paradigm Biopharmaceuticals Ltd has opened its first Australian site as part of a trial to assess injectable pentosan polysulfate sodium

03 Jun 2025 12:08 (AEST)

ASX News Healthcare Biotechnology

Dimerix (ASX:DXB) has kicked off a key trial in Japan (in terms of patient recruitment) seeking to treat inflammatory diseases.

Jonathon Davidson

30 May 2025 11:08 (AEST)

ASX News Healthcare Biotechnology

BP8 Global Ltd has made its first shipment of Indonesian seaweed to a South Korean food ingredient manufacturer

29 May 2025 14:09 (AEST)

ASX News Agriculture Consumer Cyclical Healthcare Biotechnology

New Zealand drug maker AFT Pharmaceuticals (ASX:AFP) will continue working with United States distributor Hikma Pharmaceuticals to sell key products in the U.S. after the two biotech companies put pen to paper on a new deal.Listen to the HotCopper podcast for in-depth discussions and insights on ...

26 May 2025 14:56 (AEST)

ASX News Healthcare Biotechnology

AFT Pharmaceuticals Ltd has unveiled its financial results for FY2025, announcing that it has reached a revenue of more than $200M

22 May 2025 09:33 (AEST)

ASX News The Watchlist Healthcare Biotechnology

Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.In the background, Paradigm also has a rare disease clinal asset for Mucopolysaccharidosis (MPS) and early-stage data for acute respiratory d...

Jonathon Davidson

21 May 2025 08:34 (AEST)

ASX News Healthcare Biotechnology

Amplia Therapeutics (ASX:ATX) has popped over +40% in lunchtime trades as the company reports its products provide superior outcomes...

Jonathon Davidson

15 May 2025 13:31 (AEST)

ASX News Healthcare Biotechnology

Mesoblast (ASX:MSB) has revealed the US FDA has given its flagship drug a 7 year exclusivity period, blocking...

Jonathon Davidson

15 May 2025 11:20 (AEST)

ASX News Healthcare Biotechnology

With biotech stocks broadly having a strong run in 2025, and with more of the year ahead, investors are still looking for stocks...

Jonathon Davidson

14 May 2025 10:40 (AEST)

ASX News Capital Compass Healthcare Biotechnology